EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access · CC BY-NC-ND 4.0

Optimizing Hemostasis in Hysteroscopic Myomectomy: A Randomized Clinical Trial of Vaginal Danazol Versus Diphereline in Women With Abnormal Uterine Bleeding

Sanam Bidadi, Manijeh Sayyah Melli, Simin Taghavi, Elaheh Ouladsahebmadarek, Mehri Jafari-Shobeiri, Morteza Ghojazadeh, Vahideh Rahmani

North American Proceedings in Gynecology and Obstetrics - Supplemental · 25.07.2026 · Suppl (MRSi)

DOI: 10.54053/001c.164969 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift North American Proceedings in Gynecology and Obstetrics - Supplemental, online erschienen am 25.07.2026. Verfasst von Sanam Bidadi und 6 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

To compare the efficacy of vaginal danazol versus Triptorelin in controlling intra-operative bleeding and improving surgical visualization during hysteroscopic myomectomy in women with abnormal uterine bleeding due to submucous myomas.

Design

Randomized controlled clinical trial. Materials and Methods: One hundred ninety reproductive-age women undergoing operative hysteroscopy were enrolled, and 30 were excluded. A total of 160 patients with submucous myomas were randomly assigned to receive either vaginal danazol (200 mg twice daily for 30 days preoperatively) or intramuscular triptorelin administered twice at a 28-day interval. Outcomes included severity of intra-operative bleeding, clarity of the surgical field, operative time, volume of distension media used, completion rate of surgery, and intra-operative complications. Statistical analysis compared categorical and continuous variables between groups, with significance set at p

Zitieren

APA

Bidadi, S., Melli, M. S., Taghavi, S., Ouladsahebmadarek, E., Jafari-Shobeiri, M., Ghojazadeh, M., & Rahmani, V. (2026). Optimizing Hemostasis in Hysteroscopic Myomectomy: A Randomized Clinical Trial of Vaginal Danazol Versus Diphereline in Women With Abnormal Uterine Bleeding. North American Proceedings in Gynecology and Obstetrics - Supplemental, Suppl(MRSi). https://doi.org/10.54053/001c.164969

Vancouver

Bidadi S, Melli MS, Taghavi S, Ouladsahebmadarek E, Jafari-Shobeiri M, Ghojazadeh M, et al. Optimizing Hemostasis in Hysteroscopic Myomectomy: A Randomized Clinical Trial of Vaginal Danazol Versus Diphereline in Women With Abnormal Uterine Bleeding. North American Proceedings in Gynecology and Obstetrics - Supplemental. 2026;Suppl(MRSi). doi:10.54053/001c.164969

BibTeX
@article{Bidadi2026,
  author = {Bidadi, Sanam and Melli, Manijeh Sayyah and Taghavi, Simin and Ouladsahebmadarek, Elaheh and Jafari-Shobeiri, Mehri and Ghojazadeh, Morteza and Rahmani, Vahideh},
  title = {Optimizing Hemostasis in Hysteroscopic Myomectomy: A Randomized Clinical Trial of Vaginal Danazol Versus Diphereline in Women With Abnormal Uterine Bleeding},
  journal = {North American Proceedings in Gynecology and Obstetrics - Supplemental},
  year = {2026},
  volume = {Suppl},
  number = {MRSi},
  doi = {10.54053/001c.164969}
}
Kostenlos starten →